In 2019, federally regulated producers in Canada exported roughly 3,740 kilograms (8,245 pounds) of dried cannabis for medical and scientific use, according to data Health Canada provided to MJBizDaily.
That’s 160% more than Canada’s 2018 exports, which amounted to 1,460 kilograms.
Canadian businesses exported more dried medical cannabis than ever last year, but that growth is expected to be challenged when the country’s main export destination – Germany – initiates local production.
Canada’s international cannabis shipments in 2019 likely made the country the second-largest exporter of dried medical cannabis in the world, after the Netherlands.
In total, Canada exported 4,370 kilograms of medical cannabis flower in 2019, of which 1,000 kilograms were used for dronabinol manufacturing, according to a recent report.
However, export growth for dried cannabis is showing signs of slowing, as Canadian companies struggle to find new international destinations for flower.
The data also suggests international export destinations for dried medical cannabis are few and far between, as oil and oil-derived products make up a bigger share of growth.
Germany was the main destination for Canada’s dried cannabis, as more than 94% of the 3,740.232 kilograms of dried product exported from Canada last year went to this country.
Germany imported roughly 6,714 kilograms of medical cannabis flower in 2019 from all destinations – both for pharmacy dispensing and redistribution in the EU – meaning Canada provided 52% of Germany’s imported flower. Most of the rest came from the Netherlands.
Germany is still the largest market in Europe for medical cannabis, where annual sales in 2019 amount to approximately 170 million euros ($192 million), according to the “Medical Cannabis in Europe” report.
VK PREMIUM offers an enhanced palette of consulting services to facilitate medical cannabis investments in Greece, including strategy & planning, products portfolio as of current & future market trends, land selection and licensing, grants utilizing Investment Incentive Law, design & construction of the facility in accordance with EU GMP & GACP standards and distribution strategies to secure sales success in foreign markets.
Call us at : +30 2106835560, send email to : info[@]vkmedicalcannabis.com or fill the bellow form: